Skip to content

Non-invasive Left Ventricle Contractility dp/dt as Prognostic Marker in Chest Unit Patients

Non Invasive Left Ventricle Contractility dp/dt Could be Used as a Prognostic Marker in Patients Admitted to the Emergency Department for Chest Pain

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05416112
Acronym
dp/dt
Enrollment
500
Registered
2022-06-13
Start date
2022-06-01
Completion date
2023-09-30
Last updated
2023-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain

Keywords

chest pain,, myocardial ischemia,, acute myocardial dysfunction,, plethysmography,, non invasive dp/dt.

Brief summary

Ischemic heart disease is a major public health problem with high mortality rate despite the progress in management and the resources mobilized. The idea is that myocardial ischemia is generally associated with left ventricular dysfunction and, consequently, a possible alteration of the dp/dt index. As dp/dt could be assessed non-invasively by plethysmographic method, it is interesting to investigate its prognostic performance in patients with indifferentiate chest pain.

Detailed description

Ischemic heart disease remains a major public health problem. Despite all the advances in the prognostic approach to ischemic heart disease, the risk of occurrence of major cardiovascular events is not negligible. Several scores have been proposed for chest pain stratification risk, the most widely used are the TIMI and the GRACE scores. The dP/dt max is therefore an excellent index of contractility, corresponding to the maximum level of tension developed by an isolated cardiac muscle during the isovolumic contraction phase. the investigator theorized that a less value of dp/dt would be associated with more major cardiovascular events (MACE), because ischemia reduces myocardial contractility. The current study describes non-invasive plethysmographic dp/dt changes, which could be used as a prognostic marker in patients presenting at the emergency department with acute chest pain.

Interventions

None listed

Sponsors

University of Monastir
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age over 18 years old, * acute chest pain

Exclusion criteria

* traumatic chest pain, * hemodynamic instability; * arrhythmias; * holders of a pacemaker; * STEMI

Design outcomes

Primary

MeasureTime frameDescription
MACEone monththe occurrence of a major cardiovascular event (MACE)

Countries

Tunisia

Contacts

Primary ContactNouira Semir, professor
semir.nouira@rns.tn73106046

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026